FDA Cracks Open Door For More Manufacturer Communications
Executive Summary
Two draft guidance documents would allow a broader range of communications with payers and others about information not included on device labeling, or concerning products without FDA approval.
You may also be interested in...
FDA Finalizes Q&A Guidance Docs On Manufacturer Communications, Adding A Few More Details
Two newly finalized guidance documents from US FDA help broaden the scope of acceptable manufacturer communications. One addresses communications with payers, while the other discusses communications that are consistent with approved labeling.
Unapproved Indications Guidance Proves Controversial
US FDA has collected more than 100 comments on a pair of draft guidance documents about manufacturer speech relating to unapproved devices or information not listed in device labeling. A document allowing manufacturers to disseminate some information not in the labeling drew fire from both sides, with patient groups worrying the change could pose a risk to the public, while trade groups saying the communication protections were still too narrow.
'Low-Hanging Fruit' Of Industry Comms Policy Addressed By Recent FDA Documents
Draft guidance documents issues by US FDA in January did not tackle the toughest off-label speech debates, but they did provide some useful information to guide company communications, experts said on a recent FDLI webinar.